Document is current
Any future updates will be listed below
-
Authors
Ichikawa, Hajime https://orcid.org/0000-0003-0858-1017
Iwai, Shigemitsu
Nishiwaki, Yasumi
Kikuchi, Kousuke
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (grant number JP17he1302009)
Teijin Limited
- License Information
-
More Information
Article History
Received: 6 March 2025
Accepted: 20 April 2025
First Online: 11 May 2025
Declarations
:
: Hajime Ichikawa reports a relationship with Teijin Medical Technologies Co., Ltd that includes consulting or advisory and speaking and lecture fees. Shigemitsu Iwai reports a relationship with Teijin Medical Technologies Co., Ltd that includes speaking and lecture fees. Yasumi Nishiwaki and Kousuke Kikuchi are employees of Teijin Limited.
: The authors are accountable for all aspects of the work and for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (revised in 2013). The multicenter study was registered in the Japan Registry of Clinical Trials (jRCT1080224691). Subjects provided written informed consent before enrollment. The protocol for this study was approved by the National Cerebral and Cardiovascular Center IRB (#1103) in 2019.
